Ex9536-4388
Research payments
$68,772,332
Through program year 2025, $68,772,332 in research payments was reported against Ex9536-4388, across 67,487 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,862 | 3 |
| 2024 | Research | $2,031,479 | 209 |
| 2023 | Research | $13,139,215 | 5,189 |
| 2022 | Research | $11,757,434 | 16,605 |
| 2021 | Research | $13,090,766 | 16,818 |
| 2020 | Research | $15,485,518 | 20,747 |
| 2019 | Research | $13,266,057 | 7,916 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Harvey Serota Bridgeton, MO Named on 723 payments
- Steve Fordan Dallas, TX Named on 715 payments
- Fahed Bitar Covina, CA Named on 546 payments
- Brian Snyder West Seneca, NY Named on 503 payments
- Philip Odonnell Winchester, VA Named on 501 payments
- Donald Brautigam Westfield, NY Named on 492 payments
- Maurico Concha Sarasota, FL Named on 476 payments
- Cyrus Desouza Omaha, NE Named on 466 payments
- Jeffrey Carr Tyler, TX Named on 462 payments
- Aditya Samal Houston, TX Named on 443 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.